Dubai, UAE, January 11, 2022 -Global life science innovator MGI Tech Co. Ltd. (MGI) is aiming to boost its market share in the Middle East and Asia through participation at Guangdong Week, a dedicated event taking place at the world exhibition's China Pavilion from January 11-13. The biotech company, which is headquartered in Shenzhen, Guangdong, China, will be demonstrating its sequencing platform DNBSEQ-T7* and its automation system MGISP-NE384 at the event – the technologies that form...

-- MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI's innovative equipment has been used in the detection, monitoring, surveillance, and tracing of the new variant to safeguard the global community in more than 70 countries worldwide to d...

High-throughput next generation sequencing has been successfully utilized in early screening, early diagnosis and real-time monitoring of tumor prognosis in precision medicine. Advancing case analysis and classification, course monitoring and medication guidance clinically. While manual operations in the process of library preparation and target enrichment for NGS can lead to deviations, MGI's automated sample preparation systems automate the labor-intensive and time-consuming procedures in diag...

We are pleased to see that the jury invalidated the claim of United States Patent No. 7,541,444 asserted by Illumina in the trial in the Northern District of California. This patent contained the broadest of all the asserted claims and had the longest remaining life of the five asserted patents. With this result, MGI may potentially begin selling CoolMPS technology-based products in the U.S. ten months earlier, by August 2022. In addition, the jury awarded Illumina much smaller damages (...

The National Pandemic Center (NPC) at Karolinska Institutet discovered the first case of COVID-19 Omicron variant in Sweden based on MGI ATOPlex technology. Empowered by its multiplex PCR technology, According to the data analysis results, it is confirmed that the library prep reagent produced on ATOPlex platform (High-throughput sequencing V1.1/V2.0/V3.0) can effectively monitor the Omicron variant. ATOPlex covers DNA, RNA, and DNA methylation in sequencing in multiple fields such as medicin...

As countries in Europe learn to co-exist with the COVID-19 pandemic, rapid sample testing is paramount for laboratories across the region. Automation systems on display at the event include the MGISP-960, MGISP-NE384, MGISTP-7000 and MGISTP-3000— all of which can be harnessed in the fight against the pandemic. MGI will also host daily previews of these automation systems at its booth in Hall 1, Booth 1A 23. MGISTP-7000 is a high-throughput automated sample transfer processing system tha...